Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAscent Resources Regulatory News (AST)

Share Price Information for Ascent Resources (AST)

Share Price is delayed by 15 minutes
Get Live Data
0.50    0.00 (0.00%)
Bid:
0.45
Ask:
0.55
Spread: 0.10 (22.222%)
Market Cap: £4.16m
AST Live PriceLast checked at - London Stock Exchange

Intraday Ascent Resources Share Chart

New Funding

1 Dec 2020 07:00

RNS Number : 0195H
Ascent Resources PLC
01 December 2020
 

1 December 2020

 

Ascent Resources plc

("Ascent" or the "Company")

New Funding

Ascent Resources Plc (LON: AST) the onshore Caribbean, Hispanic American and European focussed energy and natural resources company, is pleased to announce it has secured a new £500,000 loan facility.

New Funding

As announced on 29 October 2020, following a restructuring of the Company's balance sheet and historic obligations, the Company has a current debt balance of £270,020, which is due for maturity in February 2022.

The Company continues to make progress with its Cuban interests, Slovenian asset and claims under the Energy Charter Treaty and UK Slovenia Bilateral Investment Treaty as well as execution of its Special Situations Strategy. To facilitate further progress whilst minimising equity dilution, the Company has signed a loan agreement arranged and managed by Align Research Limited ("Align") to provide, in aggregate, £500,000 through an unsecured loan facility ("Loan Facility" or "Loan") provided equally by Align and RiverFort Global Opportunities PCC Ltd ("Lenders"). The Loan Facility, which is aimed at minimising dilution to shareholders at current prices, provides for the loan to be drawn down in four tranches of £125,000 each on the first business day of January, February, March and April 2021 respectively. The Loan plus a fixed coupon of 8% is repayable in full, at the election of the Lenders, either in cash or in shares at 7.5 pence per share (41.5% premium to the closing bid price on 30 November), on 31 December 2021 (the "Repayment Date"). The only exception to this will be where the Lenders request part or all of the Loan and any coupon to be utilised as consideration in paying for the warrants.

Issue of 7.5p Warrants

As part of the Loan Facility, the Company will issue a total of 6,666,666 warrants to the Lenders (the "Warrants"). The Warrants are exercisable by paying a cash price of 7.5 pence per warrant share (a 41.5% premium to the closing bid price on 30 November), or at the future placing price of any subsequent fundraise during the first 12 months of the Warrants being issued, if lower than 7.5 pence. The Warrants expire three years from the signing of the Loan agreement. In the event the Company announces that it has reached an amicable settlement agreement with the Republic of Slovenia relating to its ECT claim on or before the 31 January 2021 then any undrawn balance of the loan shall be cancelled and on a pro rata basis up to half of any Warrants outstanding may be cancellable by the Company.

Drawdown of Final £100,000 Existing Loan Facility and Exercise of Existing Warrants

 

Additionally, the Company has drawn down the final tranche of £100,000 under the previous loan facility and Align has simultaneously exercised the attached warrants ("Exercised Warrants") which were previously announced on the 6 August 2020. Align is therefore being issued with 4,000,000 Exercised Warrants shares and 320,000 Loan Coupon shares and has voluntarily agreed to a 3 months lock in on these new shares. 

Issue of Equity & TVR

The Company has also agreed to issue 480,000 ordinary shares at 7.5 pence per share ("Supplier Shares") in respect of £36,000 invoice retaining Align for a twelve months research services. These shares are subject to a lock in period of 3 months.

The issue of the Supplier Shares, the Exercised Warrants shares and the Loan Coupon shares are being carried out within the Company's existing share authority to issue ordinary shares for cash. Application will be made to the London Stock Exchange for the Supplier Shares, the Exercised Warrants shares and the Loan Coupon shares to be admitted to trading on AIM and it is expected that the Supplier Shares, the Exercised Warrants shares and the Loan Coupon shares will be admitted to trading on AIM at 8.00 a.m. on or around 7 December 2020.

In accordance with the provision of the Disclosure Guidance and Transparency Rules of the Financial Conduct Authority, the Company confirms that, following the issue of the Supplier Shares, Exercised Warrants shares, Loan Coupon shares and shares issued during the month under the Company's existing block admission, its issued ordinary share capital will comprise of 95,283,281 ordinary shares. All of the ordinary shares have equal voting rights and none of the ordinary shares are held in Treasury. The total number of voting rights in the Company will therefore be 95,283,281. The above figure may be used by shareholders as the denominator for the calculations to determine if they are required to notify their interests in, or change to their interest in, the Company.

Andrew Dennan, the Company's Chief Executive Officer, commented:

"We are pleased to have secured this flexible funding solution as we continue to progress our discussions in Slovenia alongside our growth initiatives across Cuba and multiple broader Special Situations. This is an important time for Ascent and this funding will help facilitate those key workstreams as we look to progress activities right across the portfolio."

 

Enquiries:

Ascent Resources plc

Andrew Dennan

 

Via Vigo Communications

 

WH Ireland, Nominated Adviser & Broker

James Joyce / Chris Savidge

0207 220 1666

Novum Securities, Joint Broker

John Belliss

 

0207 399 9400

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEURSARRUUAOUA
Date   Source Headline
19th May 20267:00 amRNSRiverfort Amendment, Share Settlements & TVR
6th May 20267:00 amRNSUpdate on Slovenia ECT Claim
24th Apr 20267:00 amRNSJORC Exploration Target Defined by Neometals
27th Mar 20267:00 amRNSSpecial Bonus Award - Related Party Transaction
24th Mar 20267:00 amRNSUpdate on Slovenia ECT Claim
20th Mar 20267:00 amRNSExclusive Licence with Neometals
16th Mar 20269:37 amRNSGrant of Share Options and PDMR Notification
16th Mar 20269:37 amRNSGrant of Share Options and PDMR Notification
11th Mar 20267:00 amRNSUpdate on Slovenia Disputes
28th Jan 20262:20 pmRNSGrant of Share Options / PDMR Notification
14th Jan 20267:00 amRNSUpdate on Energy Charter Treaty Claim
26th Nov 20257:00 amRNSOption Agreement for exploitation in Utah
7th Oct 20257:00 amRNSUpdate on disputes out of Slovenian Joint Venture
29th Sep 20257:00 amRNSInterim results for the period ended 30 June 2025
23rd Sep 20257:00 amRNSUpdate on Energy Charter Treaty Claim
30th Jul 20257:00 amRNSBoard Changes
23rd Jul 20253:56 pmRNSHolding(s) in Company
16th Jul 20257:00 amRNSHolding(s) in Company
15th Jul 20257:24 amRNSOperations Update and Amendment to the PSAs
9th Jul 20257:00 amRNSAppointment of CEO
3rd Jul 20257:16 amRNSSuccessful Slovenia Domestic Arbitration Outcome
27th Jun 20253:11 pmRNSResults of Annual General Meeting
27th Jun 20257:00 amRNSUpdate on Utah Operations
20th Jun 20257:00 amRNSInitiation of work-program on ARB Energy
13th Jun 20252:11 pmRNSShares for Fees, Warrants, Options and PDMR
11th Jun 20257:00 amRNSHolding(s) in Company
9th Jun 20253:05 pmRNSHolding(s) in Company
2nd Jun 20257:00 amRNSFinal Results and Notice of AGM
22nd May 20252:05 pmRNSAcquisitions, Fundraising and Debt Reprofiling
21st May 20252:48 pmRNSHolding(s) in Company
21st May 20252:46 pmRNSHolding(s) in Company
17th Apr 20257:00 amRNSECT Hearing Concluded
20th Feb 20253:18 pmRNSResult of Meeting
11th Feb 20255:26 pmRNSHolding(s) in Company
11th Feb 20251:12 pmRNSHolding(s) in Company
5th Feb 20257:00 amRNSNotice of Record Date, GM & posting of Circular
28th Jan 20255:26 pmRNSIssue of Equity & Total Voting Rights
27th Jan 20257:00 amRNS-RPublication of Research
22nd Jan 20254:28 pmRNSHolding(s) in Company
17th Jan 202512:48 pmRNSHolding(s) in Company
15th Jan 20252:05 pmRNSHolding(s) in Company
10th Jan 20257:00 amRNSAdmission Date & Total Voting Rights
30th Dec 20242:58 pmRNSHolding(s) in Company
24th Dec 20247:00 amRNS-RUpdated Corporate Presentation
24th Dec 20247:00 amRNSDirector/PDMR Shareholding
20th Dec 20247:00 amRNSInvestment in US Gas, Oil and Helium Portfolio
11th Dec 20247:00 amRNSUpdate on former JV Partner’s Insolvency Process
9th Dec 20247:00 amRNSNew Joint Venture & Board Changes
29th Oct 20243:53 pmRNSHolding(s) in Company
23rd Oct 20241:25 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.